Wealthspring Capital LLC bought a new position in shares of Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 59,360 shares of the company’s stock, valued at approximately $1,095,000. Translational Development Acquisition makes up about 1.8% of Wealthspring Capital LLC’s holdings, making the stock its 20th biggest position.
A number of other hedge funds and other institutional investors also recently modified their holdings of the company. MMCAP International Inc. SPC acquired a new position in Translational Development Acquisition in the fourth quarter valued at about $6,454,000. Wolverine Asset Management LLC acquired a new position in Translational Development Acquisition in the fourth quarter valued at about $5,716,000. Calamos Advisors LLC acquired a new position in Translational Development Acquisition in the fourth quarter valued at about $6,915,000. Finally, Tuttle Capital Management LLC acquired a new position in Translational Development Acquisition in the fourth quarter valued at about $461,000.
Translational Development Acquisition Price Performance
TDACU stock opened at $10.13 on Wednesday. The company has a 50-day moving average of $10.05. Translational Development Acquisition Corp. has a 52 week low of $10.00 and a 52 week high of $10.30.
Translational Development Acquisition Company Profile
Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.
Further Reading
- Five stocks we like better than Translational Development Acquisition
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- The Role Economic Reports Play in a Successful Investment Strategy
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- What is a Death Cross in Stocks?
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report).
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.